The <scp>IL</scp> ‐10/ <scp>IL</scp> ‐6 Ratio and the Risk Score: Two Cytokines‐Based Predictors for Malignancy‐Associated Hemophagocytic Lymphohistiocytosis in Adults (M‐ <scp>HLHa</scp> )
The predictive value of cytokines (CK) for malignancy-associated adult hemophagocytic lymphohistiocytosis (M-HLHa) remains uncertain. We evaluated a cytokine-based Risk Score (RS) and the IL-10/IL-6 Ratio to predict M-HLHa. Adult patients (n = 112) from the French HLH cohort (NCT02113917) with complete data for nine key HLH related CK measured by Luminex were first analyzed. Logistic regression was performed, and a RS was subsequently derived and internally validated. In a post hoc analysis, the IL-10/IL-6 ratio obtained using the ELLA cytokine assay was evaluated in 75 patients, 54 of whom also had Luminex testing, plus 25 additional patients from the cohort. The RS and IL-10/IL-6 ratio were then jointly assessed in the 54 patients with results from both platforms. Among the 112 patients, 45 had M-HLHa and 67 non M-HLHa; median age was 48 years and 64 (57%) were male. Eight variables were associated with M-HLHa, of which four were retained in the logistic model: age > 48 years (2.9[1.12-7.33], p = 0.03), TNF-α ≤ 43 pg/mL (3.2[1.16-8.61], p = 0.02), IL-18 > 574 pg/mL (4.9[1.89-12.75], p = 0.001), and IL-10/IL-6 ≥ 1.5 (2.7[1.01-7.31], p = 0.04), with respective weights of 11, 12, 16, and 10. A RS ≥ 20 increased the odds of M-HLHa 17-fold (17.2 [5.4-54.5], p < 0.0001). The IL-10/IL-6 ratio alone (n = 75) showed good performance (AUC 0.83). In the 54 patients with both assays, the RS and IL-10/IL-6 ratio preserved their diagnostic performance (AUC 0.87 and 0.79, respectively). These data support the RS and IL-10/IL-6 Ratio as useful tools to improve the identification of M-HLHa in adults. Trial Registration: clinicaltrials.gov NCT02113917.
Authors
- David Launay (ORCID: https://orcid.org/0000-0003-1840-1817)
- Stéphanie Chhun (ORCID: https://orcid.org/0000-0001-6278-4128)
- Nanthara Sritharan
- Felipe Suarez
- Raphaël Lhote (ORCID: https://orcid.org/0000-0002-2729-4606)
- Morgane Cheminant (ORCID: https://orcid.org/0000-0002-2070-9581)
- Yves Lepelletier (ORCID: https://orcid.org/0000-0001-7746-5170)
- Marine Gil (ORCID: https://orcid.org/0000-0002-3885-7806)
- Geneviève de Saint Basile (ORCID: https://orcid.org/0000-0002-1913-5269)
- Marc Michel (ORCID: https://orcid.org/0000-0002-9822-7400)
- Jean‐François Viallard (ORCID: https://orcid.org/0000-0001-7500-9323)
- Olivier Hermine (ORCID: https://orcid.org/0000-0003-2574-3874)
- Coralie Bloch‐Queyrat (ORCID: https://orcid.org/0000-0002-8591-3145)
- Marouane Boubaya
- Jean‐Marie Michot (ORCID: https://orcid.org/0000-0003-3482-3331)
- Francois Liffermann
- C. Larroche
- Louis Terriou
- Geoffrey Urbansk
- Estibaliz Lazaro
- Olivier Lambotte
- the French HLH Study Group
- Pierre Morel
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Institut Gustave Roussy (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Institut Necker Enfants Malades (FR)
- Université Sorbonne Paris Nord (FR)
- Sorbonne Paris Cité (FR)
- CEA Paris-Saclay - Etablissement de Fontenay-aux-roses (FR)
- Centre Hospitalier de Lens (FR)
- Immunology from Concept and Experiments to Translation (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- CEA Paris-Saclay (FR)
- Infectious Disease Models and Innovative Therapies (FR)
- Hôpital Avicenne (FR)
- Délégation Paris 6 (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Centre Hospitalier de Dax –Côte d’Argent (FR)
- Institute of Normal and Pathological Physiology of the Slovak Academy of Sciences (SK)
- Bicêtre Hospital (FR)
- Institut des Maladies Génétiques Imagine (FR)
- Université d'Angers (FR)
- Université Lille Nord de France (FR)
Publication Details
- Journal
- American Journal of Hematology
- Published
- 2026-06-16
- DOI
- https://doi.org/10.1002/ajh.70410
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00